Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8111 S Emerson Ave
Suite 204
Indianapolis, IN 46237Phone+1 317-528-2555Fax+1 317-528-2566- Is this information wrong?
Education & Training
- University of North Carolina HospitalsFellowship, Gynecologic Oncology, 1986 - 1988
- Indiana University School of MedicineResidency, Obstetrics and Gynecology, 1982 - 1986
- Indiana University School of MedicineClass of 1982
Certifications & Licensure
- IN State Medical License 1982 - 2023
- NC State Medical License 1986 - 1998
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Start of enrollment: 1998 Dec 01
- Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva Start of enrollment: 2005 Jan 01
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsFinal survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study.Krishnansu S Tewari, Michael W Sill, Michael J Birrer, Richard T Penson, Helen Huang, David H Moore, Lois M Ramondetta, Lisa M Landrum, Ana Oaknin, Thomas J Reid, Mari...> ;Gynecologic Oncology. 2023 Apr 1
- 11 citationsCirculating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)Krishnansu S. Tewari, Michael W. Sill, Bradley J. Monk, Richard T. Penson, David H. Moore, Heather A. Lankes, Lois M. Ramondetta, Lisa M. Landrum, Leslie M. Randall, A...> ;Molecular Cancer Therapeutics. 2020 Aug 26
- 339 citationsBevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncolog...Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas J. Reid, Mario M. Leitao, Helen Michael,...> ;Lancet. 2017 Oct 7
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Women's Imaging and Radiation Oncology-Gynecology, American College of Radiology 2015 - Present
Professional Memberships
- Member
- Fellow
- Member
Hospital Affiliations
- Community Hospital NorthIndianapolis, Indiana
- Community Hospital SouthIndianapolis, Indiana
- Richard L. Roudebush Veterans Affairs Medical CenterIndianapolis, Indiana
- Indiana University Health University HospitalIndianapolis, Indiana
- Indiana University Health North HospitalCarmel, Indiana
- Indiana University Health West HospitalAvon, Indiana
- Franciscan Health IndianapolisIndianapolis, Indiana
- Eskenazi HealthIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: